DRTS
Alpha Tau Medical Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$12.62
+2.69%Next report
Analyst consensus
- Next report date
- Nov 19, 2026
- EPS estimate
- -$0.14
- Revenue estimate
- $243.3K
Latest reported
- Last report date
- Aug 10, 2026
- EPS actual
- -$0.50
- EPS estimate
- -$0.14
- Revenue actual
- $100.0K
- Revenue estimate
- $144.5K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -96.8%
- Revenue beats (12Q)
- 0
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $23
- PT range
- $16 – $30
- Analysts
- 2
2 Buy0 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 10, 2026 | -$0.14 | -$0.50 | Miss -254.91% | $100.0K |
| May 18, 2026 | -$0.13 | -$0.26 | Miss -100.00% | — |
| Mar 9, 2026 | -$0.12 | -$0.14 | Miss -15.69% | — |
| Nov 20, 2025 | -$0.12 | -$0.14 | Miss -16.67% | — |
| May 19, 2025 | -$0.14 | -$0.12 | Beat 14.29% | — |
| Mar 12, 2025 | -$0.13 | -$0.13 | In line | — |
| Aug 14, 2024 | -$0.13 | -$0.11 | Beat 15.38% | — |
| May 20, 2024 | -$0.13 | -$0.11 | Beat 15.38% | — |
| Mar 7, 2024 | -$0.13 | -$0.11 | Beat 15.38% | — |
| Nov 16, 2023 | -$0.12 | -$0.07 | Beat 41.67% | — |
| Aug 28, 2023 | -$0.13 | -$0.12 | Beat 7.69% | — |
| May 23, 2023 | -$0.09 | -$0.12 | Miss -33.33% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 19, 2026